Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Effectiveness of a stepwise Pseudomonas aeruginosa eradication protocol in children with cystic fibrosis.

Blanchard AC, Horton E, Stanojevic S, Taylor L, Waters V, Ratjen F.

J Cyst Fibros. 2017 May;16(3):395-400. doi: 10.1016/j.jcf.2017.01.007. Epub 2017 Feb 9.

2.

Open label study of inhaled aztreonam for Pseudomonas eradication in children with cystic fibrosis: The ALPINE study.

Tiddens HA, De Boeck K, Clancy JP, Fayon M, H G M A, Bresnik M, Derchak A, Lewis SA, Oermann CM; ALPINE study investigators.

J Cyst Fibros. 2015 Jan;14(1):111-9. doi: 10.1016/j.jcf.2014.06.003. Epub 2014 Aug 1.

3.

The success of the different eradication therapy regimens for Pseudomonas aeruginosa in cystic fibrosis.

Emiralioglu N, Yalcin E, Meral A, Sener B, Dogru D, Ozcelik U, Kiper N.

J Clin Pharm Ther. 2016 Aug;41(4):419-23. doi: 10.1111/jcpt.12407. Epub 2016 Jun 16.

PMID:
27311742
4.

Standard care versus protocol based therapy for new onset Pseudomonas aeruginosa in cystic fibrosis.

Mayer-Hamblett N, Rosenfeld M, Treggiari MM, Konstan MW, Retsch-Bogart G, Morgan W, Wagener J, Gibson RL, Khan U, Emerson J, Thompson V, Elkin EP, Ramsey BW; EPIC; ESCF Investigators.

Pediatr Pulmonol. 2013 Oct;48(10):943-53. doi: 10.1002/ppul.22693. Epub 2013 Jul 2.

5.

Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.

Langton Hewer SC, Smyth AR.

Cochrane Database Syst Rev. 2014 Nov 10;(11):CD004197. doi: 10.1002/14651858.CD004197.pub4. Review. Update in: Cochrane Database Syst Rev. 2017 Apr 25;4:CD004197.

PMID:
25383937
6.

Eradication failure of newly acquired Pseudomonas aeruginosa isolates in cystic fibrosis.

Cohen-Cymberknoh M, Gilead N, Gartner S, Rovira S, Blau H, Mussaffi H, Rivlin J, Gur M, Shteinberg M, Bentur L, Livnat G, Aviram M, Picard E, Tenenbaum A, Armoni S, Breuer O, Shoseyov D, Kerem E.

J Cyst Fibros. 2016 Nov;15(6):776-782. doi: 10.1016/j.jcf.2016.04.006. Epub 2016 May 1.

7.

Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis.

Mayer-Hamblett N, Kronmal RA, Gibson RL, Rosenfeld M, Retsch-Bogart G, Treggiari MM, Burns JL, Khan U, Ramsey BW; EPIC Investigators.

Pediatr Pulmonol. 2012 Feb;47(2):125-34. doi: 10.1002/ppul.21525. Epub 2011 Aug 9.

8.

Comparison of two treatment regimens for eradication of Pseudomonas aeruginosa infection in children with cystic fibrosis.

Proesmans M, Vermeulen F, Boulanger L, Verhaegen J, De Boeck K.

J Cyst Fibros. 2013 Jan;12(1):29-34. doi: 10.1016/j.jcf.2012.06.001. Epub 2012 Jul 2.

9.

Effectiveness of inhaled tobramycin in eradicating Pseudomonas aeruginosa in children with cystic fibrosis.

Stanojevic S, Waters V, Mathew JL, Taylor L, Ratjen F.

J Cyst Fibros. 2014 Mar;13(2):172-8. doi: 10.1016/j.jcf.2013.09.002. Epub 2013 Oct 3.

10.

Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infection.

Greenwood J, Schwarz C, Sommerwerck U, Nash EF, Tamm M, Cao W, Mastoridis P, Debonnett L, Hamed K.

Ther Adv Respir Dis. 2017 Jul;11(7):249-260. doi: 10.1177/1753465817710596.

11.

Clearance of initial mucoid Pseudomonas aeruginosa in patients with cystic fibrosis.

Troxler RB, Hoover WC, Britton LJ, Gerwin AM, Rowe SM.

Pediatr Pulmonol. 2012 Nov;47(11):1113-22. doi: 10.1002/ppul.22543. Epub 2012 Apr 11.

12.

Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial.

Ratjen F, Munck A, Kho P, Angyalosi G; ELITE Study Group.

Thorax. 2010 Apr;65(4):286-91. doi: 10.1136/thx.2009.121657. Epub 2009 Dec 8.

PMID:
19996339
13.

Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients.

Taccetti G, Campana S, Festini F, Mascherini M, Döring G.

Eur Respir J. 2005 Sep;26(3):458-61.

14.

Impact of Sustained Eradication of New Pseudomonas aeruginosa Infection on Long-term Outcomes in Cystic Fibrosis.

Mayer-Hamblett N, Kloster M, Rosenfeld M, Gibson RL, Retsch-Bogart GZ, Emerson J, Thompson V, Ramsey BW.

Clin Infect Dis. 2015 Sep 1;61(5):707-15. doi: 10.1093/cid/civ377. Epub 2015 May 13.

15.

Ciprofloxacin during upper respiratory tract infections to reduce Pseudomonas aeruginosa infection in paediatric cystic fibrosis: a pilot study.

Connett GJ, Pike KC, Legg JP, Cathie K, Dewar A, Foote K, Harris A, Faust SN.

Ther Adv Respir Dis. 2015 Dec;9(6):272-80. doi: 10.1177/1753465815601571. Epub 2015 Sep 4.

PMID:
26341118
16.

Tobramycin inhalation powder in cystic fibrosis patients: response by age group.

Geller DE, Nasr SZ, Piggott S, He E, Angyalosi G, Higgins M.

Respir Care. 2014 Mar;59(3):388-98. doi: 10.4187/respcare.02264. Epub 2013 Aug 27.

17.

Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.

Langton Hewer SC, Smyth AR.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD004197. doi: 10.1002/14651858.CD004197.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;11:CD004197.

PMID:
19821321
18.

Early anti-pseudomonal acquisition in young patients with cystic fibrosis: rationale and design of the EPIC clinical trial and observational study'.

Treggiari MM, Rosenfeld M, Mayer-Hamblett N, Retsch-Bogart G, Gibson RL, Williams J, Emerson J, Kronmal RA, Ramsey BW; EPIC Study Group.

Contemp Clin Trials. 2009 May;30(3):256-68. doi: 10.1016/j.cct.2009.01.003. Epub 2009 Jan 15.

19.

Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.

Knudsen PK, Olesen HV, Høiby N, Johannesson M, Karpati F, Laerum BN, Meyer P, Pressler T, Lindblad A; Scandinavian CF Study Consortium (SCFSC).

J Cyst Fibros. 2009 Mar;8(2):135-42. doi: 10.1016/j.jcf.2008.11.001. Epub 2009 Jan 20.

20.

Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.

Hansen CR, Pressler T, Høiby N.

J Cyst Fibros. 2008 Nov;7(6):523-30. doi: 10.1016/j.jcf.2008.06.009. Epub 2008 Aug 9.

Supplemental Content

Support Center